These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 19700018

  • 1. The histologic spectrum of epithelial neoplasms induced by sorafenib.
    Kwon EJ, Kish LS, Jaworsky C.
    J Am Acad Dermatol; 2009 Sep; 61(3):522-7. PubMed ID: 19700018
    [Abstract] [Full Text] [Related]

  • 2. Sorafenib-induced erythema multiforme in metastatic renal cell carcinoma.
    Bilaç C, Müezzinoğlu T, Ermertcan AT, Kayhan TC, Temeltaş G, Oztürkcan S, Temiz P.
    Cutan Ocul Toxicol; 2009 Sep; 28(2):90-2. PubMed ID: 19514932
    [Abstract] [Full Text] [Related]

  • 3. Eruptive squamous cell carcinomas with keratoacanthoma-like features in a patient treated with sorafenib.
    Lynch MC, Straub R, Adams DR.
    J Drugs Dermatol; 2011 Mar; 10(3):308-10. PubMed ID: 21369650
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prospective study of the cutaneous adverse effects of sorafenib, a novel multikinase inhibitor.
    Autier J, Escudier B, Wechsler J, Spatz A, Robert C.
    Arch Dermatol; 2008 Jul; 144(7):886-92. PubMed ID: 18645140
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sorafenib-induced psoriasiform eruption in a patient with metastatic thyroid carcinoma.
    Diamantis ML, Chon SY.
    J Drugs Dermatol; 2010 Feb; 9(2):169-71. PubMed ID: 20214183
    [Abstract] [Full Text] [Related]

  • 13. Keratoacanthomas and squamous cell carcinomas in patients receiving sorafenib.
    Arnault JP, Wechsler J, Escudier B, Spatz A, Tomasic G, Sibaud V, Aractingi S, Grange JD, Poirier-Colame V, Malka D, Soria JC, Mateus C, Robert C.
    J Clin Oncol; 2009 Aug 10; 27(23):e59-61. PubMed ID: 19597016
    [No Abstract] [Full Text] [Related]

  • 14. Cutaneous squamous cell carcinoma and inflammation of actinic keratoses associated with sorafenib.
    Dubauskas Z, Kunishige J, Prieto VG, Jonasch E, Hwu P, Tannir NM.
    Clin Genitourin Cancer; 2009 Jan 10; 7(1):20-3. PubMed ID: 19213663
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.